Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

1.

The Clearer BENEFITS of Belatacept.

N. Engl. J. Med.
Heher E, Markmann JF.
| Jan 28, 2016
2.

Eluxadoline for Irritable Bowel Syndrome with Diarrhea.

N. Engl. J. Med.
Lembo AJ, Lacy BE, Zuckerman MJ, Schey R, Dove LS, Andrae DA, Davenport JM, McIntyre G, Lopez R, Turner L, Covington PS.
| Jan 21, 2016
3.

Time for a Patient-Driven Health Information Economy?

N. Engl. J. Med.
Mandl KD, Kohane IS.
| Jan 21, 2016
4.

ACOs and High-Cost Patients.

N. Engl. J. Med.
Powers BW, Chaguturu SK.
| Jan 21, 2016
5.

Regulating Homeopathic Products - A Century of Dilute Interest.

N. Engl. J. Med.
Podolsky SH, Kesselheim AS.
| Jan 21, 2016
6.

Medical Taylorism.

N. Engl. J. Med.
Hartzband P, Groopman J.
| Jan 14, 2016
7.

Improving the Prediction of Preeclampsia.

N. Engl. J. Med.
Seely EW, Solomon CG.
| Jan 7, 2016
8.

Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies.

N. Engl. J. Med.
Ware JS, Li J, Mazaika E, Yasso CM, DeSouza T, Cappola TP, Tsai EJ, Hilfiker-Kleiner D, Kamiya CA, Mazzarotto F, Cook SA, Halder I, Prasad SK, Pisarcik J, Hanley-Yanez K, Alharethi R, Damp J, Hsich E, Elkayam U, Sheppard R, Kealey A, Alexis J, Ramani G, Safirstein J, Boehmer J, Pauly DF, Wittstein IS, Thohan V, Zucker MJ, Liu P, Gorcsan J, McNamara DM, Seidman CE, Seidman JG, Arany Z, McNamara DM.
| Jan 21, 2016
9.

Choosing Benefits while Balancing Risks.

N. Engl. J. Med.
Greene MF, Ecker JL.
| Dec 31, 2015
10.

Selexipag for the Treatment of Pulmonary Arterial Hypertension.

N. Engl. J. Med.
Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, Preiss R, Rubin LJ, Di Scala L, Tapson V, Adzerikho I, Liu J, Moiseeva O, Zeng X, Simonneau G, McLaughlin VV, Williams PG, Beghetti M, Corris P, Pepke-Zaba J, Souza R, DeMets DL, Gomberg-Maitland M, Greenberg BH, Schulman S, Douketis J, Amuchastegui M.
| Dec 24, 2015
11.

Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F.

N. Engl. J. Med.
Shaw AT, Friboulet L, Leshchiner I, Gainor JF, Bergqvist S, Brooun A, Burke BJ, Deng YL, Liu W, Dardaei L, Frias RL, Schultz KR, Logan J, James LP, Smeal T, Timofeevski S, Katayama R, Iafrate AJ, Le L, McTigue M, Getz G, Johnson TW, Engelman JA.
| Jan 7, 2016
12.

Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia.

N. Engl. J. Med.
Byrd JC, Harrington B, O'Brien S, Jones JA, Schuh A, Devereux S, Chaves J, Wierda WG, Awan FT, Brown JR, Hillmen P, Stephens DM, Ghia P, Barrientos JC, Pagel JM, Woyach J, Johnson D, Huang J, Wang X, Kaptein A, Lannutti BJ, Covey T, Fardis M, McGreivy J, Hamdy A, Rothbaum W, Izumi R, Diacovo TG, Johnson AJ, Furman RR.
| Jan 28, 2016
13.

Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.

N. Engl. J. Med.
Roberts AW, Davids MS, Pagel JM, Kahl BS, Puvvada SD, Gerecitano JF, Kipps TJ, Anderson MA, Brown JR, Gressick L, Wong S, Dunbar M, Zhu M, Desai MB, Cerri E, Heitner Enschede S, Humerickhouse RA, Wierda WG, Seymour JF.
| Jan 28, 2016
14.

Estimating the Long-Term Treatment Benefits of Sacubitril-Valsartan.

N. Engl. J. Med.
Claggett B, Packer M, McMurray JJ, Swedberg K, Rouleau J, Zile MR, Jhund P, Lefkowitz M, Shi V, Solomon SD.
| Dec 3, 2015
15.

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.

N. Engl. J. Med.
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, Aizenberg D.
| Dec 3, 2015
16.

Tenuous Tether.

N. Engl. J. Med.
Edelman ER, Weber BN.
| Dec 3, 2015
17.

Hypoplastic Metatarsals--Beyond Cosmesis.

N. Engl. J. Med.
Sharma A, Phillips AJ, Jüppner H.
| Nov 26, 2015
18.

IMAGES IN CLINICAL MEDICINE. Tension Pneumoperitoneum.

N. Engl. J. Med.
Kaafarani HM.
| Nov 19, 2015
19.

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.

N. Engl. J. Med.
Foster GR, Afdhal N, Roberts SK, Bräu N, Gane EJ, Pianko S, Lawitz E, Thompson A, Shiffman ML, Cooper C, Towner WJ, Conway B, Ruane P, Bourlière M, Asselah T, Berg T, Zeuzem S, Rosenberg W, Agarwal K, Stedman CA, Mo H, Dvory-Sobol H, Han L, Wang J, McNally J, Osinusi A, Brainard DM, McHutchison JG, Mazzotta F, Tran TT, Gordon SC, Patel K, Reau N, Mangia A, Sulkowski M, Afdhal N.
| Dec 31, 2015
20.

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.

N. Engl. J. Med.
Curry MP, O'Leary JG, Bzowej N, Muir AJ, Korenblat KM, Fenkel JM, Reddy KR, Lawitz E, Flamm SL, Schiano T, Teperman L, Fontana R, Schiff E, Fried M, Doehle B, An D, McNally J, Osinusi A, Brainard DM, McHutchison JG, Brown RS, Charlton M, Al-Assi TM.
| Dec 31, 2015